Annual Retained Earnings
-$163.42 M
-$75.52 M-85.91%
December 31, 2023
Summary
- As of February 8, 2025, AVTE annual retained earnings is -$163.42 million, with the most recent change of -$75.52 million (-85.91%) on December 31, 2023.
- During the last 3 years, AVTE annual retained earnings has fallen by -$150.02 million (-1118.95%).
- AVTE annual retained earnings is now -4385.97% below its all-time high of -$3.64 million, reached on December 31, 2019.
Performance
AVTE Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$227.62 M
-$16.24 M-7.68%
September 30, 2024
Summary
- As of February 8, 2025, AVTE quarterly retained earnings is -$227.62 million, with the most recent change of -$16.24 million (-7.68%) on September 30, 2024.
- Over the past year, AVTE quarterly retained earnings has dropped by -$64.20 million (-39.28%).
- AVTE quarterly retained earnings is now -1597.78% below its all-time high of -$13.41 million, reached on December 31, 2020.
Performance
AVTE Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
AVTE Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -85.9% | -39.3% |
| 3 y3 years | -1119.0% | -39.3% |
| 5 y5 years | -4386.0% | -39.3% |
AVTE Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -349.1% | at low | -525.5% | at low |
| 5 y | 5-year | -4386.0% | at low | -1597.8% | at low |
| alltime | all time | -4386.0% | at low | -1597.8% | at low |
Aerovate Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$227.62 M(+7.7%) |
| Jun 2024 | - | -$211.38 M(+13.3%) |
| Mar 2024 | - | -$186.61 M(+14.2%) |
| Dec 2023 | -$163.42 M(+85.9%) | -$163.42 M(+14.3%) |
| Sep 2023 | - | -$143.01 M(+15.8%) |
| Jun 2023 | - | -$123.45 M(+18.2%) |
| Mar 2023 | - | -$104.42 M(+18.8%) |
| Dec 2022 | -$87.90 M | -$87.90 M(+20.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -$72.88 M(+22.9%) |
| Jun 2022 | - | -$59.29 M(+25.3%) |
| Mar 2022 | - | -$47.30 M(+30.0%) |
| Dec 2021 | -$36.39 M(+171.4%) | -$36.39 M(+29.2%) |
| Sep 2021 | - | -$28.17 M(+28.1%) |
| Jun 2021 | - | -$21.98 M(+35.7%) |
| Mar 2021 | - | -$16.20 M(+20.8%) |
| Dec 2020 | -$13.41 M(+268.0%) | -$13.41 M |
| Dec 2019 | -$3.64 M | - |
FAQ
- What is Aerovate Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Aerovate Therapeutics?
- What is Aerovate Therapeutics annual retained earnings year-on-year change?
- What is Aerovate Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Aerovate Therapeutics?
- What is Aerovate Therapeutics quarterly retained earnings year-on-year change?
What is Aerovate Therapeutics annual retained earnings?
The current annual retained earnings of AVTE is -$163.42 M
What is the all time high annual retained earnings for Aerovate Therapeutics?
Aerovate Therapeutics all-time high annual retained earnings is -$3.64 M
What is Aerovate Therapeutics annual retained earnings year-on-year change?
Over the past year, AVTE annual retained earnings has changed by -$75.52 M (-85.91%)
What is Aerovate Therapeutics quarterly retained earnings?
The current quarterly retained earnings of AVTE is -$227.62 M
What is the all time high quarterly retained earnings for Aerovate Therapeutics?
Aerovate Therapeutics all-time high quarterly retained earnings is -$13.41 M
What is Aerovate Therapeutics quarterly retained earnings year-on-year change?
Over the past year, AVTE quarterly retained earnings has changed by -$64.20 M (-39.28%)